- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07946640
A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy Adults
This is a decentralized, single-arm, within-subject crossover clinical study evaluating the effects of Driscoll's Raspberries and Driscoll's Blackberries on postprandial glycemic response, satiety, and consumer appeal in healthy adults aged 18-65 years. Forty participants will each consume three standardized breakfast meals - a raspberry-inclusive meal, a blackberry-inclusive meal, and a sugar-reference meal - in any order over a two-week period, wearing a continuous glucose monitor (CGM) throughout.
All study activities are conducted remotely at participants' homes. CGM data will be used to compute incremental area under the glucose-time curve (iAUC) over the two-hour postprandial window following each meal. Self-reported questionnaires will assess satiety, energy, digestive comfort, and sensory appeal following each meal condition.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Jamie Bassmann
- Email: jamie.bassmann@driscolls.com
Luoghi di studio
-
-
Nevada
-
Las Vegas, Nevada, Stati Uniti, 89101
- Citruslabs
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Be male or female.
- Adult aged 18-65 years.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- Willing and able to wear a CGM device continuously for the two-week study period.
- Willing to consume three standardized breakfast meals over the two-week study period, each consumed after an overnight fast of at least eight hours, with a minimum of 24 hours between each standardized meal event.
- Willing to purchase and eat fresh Driscoll's Raspberries and Driscoll's Blackberries from a local retailer using a sponsor-provided berry stipend for use in the standardized meals.
- Have reasonable access to a retailer that sells Driscoll's-branded raspberries and blackberries.
- Have access to a smartphone or computer with a reliable internet connection.
- Willing to maintain the same diet and exercise regimen consistently throughout the study duration.
- Willing and able to complete all required digital surveys via the Citruslabs study platform at Baseline, and at the end of the day following Meal 1, Meal 2, and Meal 3.
- Resides in the United States.
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Anyone currently undergoing treatment for cancer, or have had a serious illness requiring hospitalization in the last 3 months.
- Known or suspected allergy or hypersensitivity to raspberries, blackberries, or other berry species.
- Known or suspected allergy, intolerance, or sensitivity to oats or gluten that would prevent consumption of the standardized oat-based meal component.
- Current diagnosis of type 1 diabetes, type 2 diabetes, or prediabetes.
- Current use of any medications or supplements known to significantly affect blood glucose levels, including but not limited to: insulin, metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, sulfonylureas, or other glucose-lowering agents.
- Known skin sensitivity to adhesives or prior documented adverse reaction to CGM sensors or similar transcutaneous monitoring devices.
- Presence of implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator) that may be contraindicated with CGM device use, per the CGM manufacturer's specifications.
- Pregnant, breastfeeding, or planning to become pregnant during the study period.
- Anyone with a history of substance abuse.
- Anyone who is currently a smoker or has been a smoker in the past three months.
- Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.
- History of an eating disorder currently requiring active clinical treatment.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Driscoll's Blackberries Arm
|
All participants complete all three meal conditions in any sequence. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Incremental Area Under the Glucose-Time Curve (iAUC) - Raspberry Meal vs. Sugar-Reference Meal
Lasso di tempo: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of raspberry meal vs. sugar-reference meal |
Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Incremental Area Under the Glucose-Time Curve (iAUC) - Blackberry Meal vs. Sugar-Reference Meal
Lasso di tempo: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of blackberry meal vs. sugar-reference meal |
Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Self-Reported Hunger
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Fullness
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Desire to Eat
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Energy Levels
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Digestive Comfort
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Bloating
Lasso di tempo: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Perceived Sweetness of Meal
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Palatability of Meal
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Motivation to Eat Healthier the Rest of the Day
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Overall Acceptability of Meal
Lasso di tempo: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Collaboratori e investigatori
Sponsor
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- DRISC-40019
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .